Top Markets
Coin of the day
Zelluna ASA Zelluna ASA

Zelluna ASA

ZLNA
Rank in Stocks #23821
Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes... Established in 2016 and headquartered in Oslo, Norway, Zelluna ASA specializes in the creation of T-cell receptor (TCR) cellular immunotherapy treatments aimed at combating solid tumors.
Share Price
$2.34
Last synced: 2026-08-21
Market Cap
$68.75M
Change (1 day)
1.36%
Change (1 year)
67.90%
Country
NO
Trade Zelluna ASA (ZLNA)

Category

P/E ratio for Zelluna ASA (ZLNA)
P/E ratio as of 2026 TTM: 0
According to Zelluna ASA latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Zelluna ASA from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
-7.93 -
US
32.46 -
AU
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.